• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Zoetis (NY:ZTS)

    81.32 +1.25 (+1.56%)
    Official Closing Price Updated: 7:00 PM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Zoetis

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Zoetis Inc. (ZTS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Zoetis to Participate in Upcoming Investor Conferences
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Declares Third Quarter 2026 Dividend
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith 
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Zoetis Announces First Quarter 2026 Results
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Participate in Upcoming Investor Conferences
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Reports Fourth Quarter and Full Year 2025 Results
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Declares Second Quarter 2026 Dividend
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis to Host Innovation Webcast
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Announces Third Quarter 2025 Results
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
    From Zoetis Inc.
    Via Business Wire
    News headline image
    Zoetis Appoints Stephanie Tilenius to its Board of Directors
    From Zoetis Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.